Back to today’s briefing

Story perspectives

Exoskeletons: Mixed Results as Consumer Market Awakens

1/26/2026

26 5 Full Breakdown

Summary

Story summary

At CES 2026, Dnsys and Hypershell showcased their latest personal exoskeletons.
The devices move from medical use to consumer markets, with projected growth from over $500 million in 2025 to more than $2 billion by 2030.
Testing shows mixed results.
A 76-year-old user found climbing easier, but Chris Haslam found the devices hindering.
Both companies claim health benefits, but experiences vary, and progress depends on technology and user feedback.

1 of 1

Story summary

At CES 2026, Dnsys and Hypershell showcased their latest personal exoskeletons.
The devices move from medical use to consumer markets, with projected growth from over $500 million in 2025 to more than $2 billion by 2030.
Testing shows mixed results.
A 76-year-old user found climbing easier, but Chris Haslam found the devices hindering.
Both companies claim health benefits, but experiences vary, and progress depends on technology and user feedback.